Mechanisms and Applications of the Anti-Inflammatory Effects of Photobiomodulation
Technology context Photobiomodulation mechanism research - largely preclinical, including laser and LED sources
Finding: Identifies cytochrome c oxidase and calcium ion channels as primary chromophores and describes a pronounced biphasic dose response in which low light levels stimulate and high levels inhibit.
Main limitation: Largely mechanistic and preclinical: demonstrating a cellular pathway is not the same as demonstrating a clinical outcome at consumer device doses.
Executive summary
This review is the reason the red light category has a scientific basis at all, and also the reason its marketing is so often wrong.
It identifies the primary chromophores - the molecules that absorb the light - as cytochrome c oxidase in mitochondria and calcium ion channels, possibly mediated by light absorption by opsins. Secondary effects of photon absorption include increases in ATP, a brief burst of reactive oxygen species, an increase in nitric oxide, and modulation of calcium levels. Tertiary effects include activation of transcription factors leading to improved cell survival, increased proliferation and migration, and new protein synthesis.
The single most important sentence for a buyer is this: there is a pronounced biphasic dose response, whereby low levels of light have stimulating effects while high levels of light have inhibitory effects.
The review also reports a context-dependence that is easy to misread. Photobiomodulation can produce reactive oxygen species in normal cells, but in oxidatively stressed cells or animal models of disease, ROS levels are lowered. Similarly it can activate NF-kB in normal quiescent cells, while in activated inflammatory cells, inflammatory markers were decreased.
Reduction in inflammation is described as one of the most reproducible effects, demonstrated across joints, traumatic injuries, lung disorders and the brain - predominantly in animal models.
Why this research matters
The biphasic dose response is the concept that should govern every red light purchase, and almost no marketing mentions it. If more light past a certain point produces less effect, then buying the highest-output panel available is not a strategy - it is a way to overshoot.
This review is also where the mechanism claims on product pages originate. Reading it shows how far those claims have travelled from cell cultures to consumer packaging.
Study design
- Study type
- Mechanistic review
- Scope
- Molecular and cellular mechanisms of photobiomodulation and their anti-inflammatory applications
- Evidence base
- In vitro cell studies, animal models of disease, some human contexts
- Primary chromophores identified
- Cytochrome c oxidase in mitochondria; calcium ion channels, possibly mediated by opsins
- Secondary effects described
- Increased ATP, brief burst of reactive oxygen species, increased nitric oxide, modulation of calcium levels
- Tertiary effects described
- Transcription factor activation, improved cell survival, increased proliferation and migration, new protein synthesis
- Dose relationship
- Pronounced biphasic - low levels stimulate, high levels inhibit
- Tissues discussed
- Joints, traumatic injuries, lung, brain, abdominal fat, wounds, spinal cord
- Wavelengths, irradiance and doses
- Vary across the studies discussed; not standardised
- Human clinical trials
- Not the focus of this review
What the researchers found
Light absorption occurs primarily at cytochrome c oxidase in the mitochondria and at calcium ion channels, possibly mediated by opsins.
Secondary effects include increases in ATP, a brief burst of reactive oxygen species, an increase in nitric oxide, and modulation of calcium levels. Tertiary effects include activation of a wide range of transcription factors leading to improved cell survival, increased proliferation and migration, and new protein synthesis.
A pronounced biphasic dose response is described: low levels of light have stimulating effects, high levels have inhibitory effects.
In oxidatively stressed cells and animal models of disease, ROS levels were lowered, and photobiomodulation up-regulated anti-oxidant defences and reduced oxidative stress. In activated inflammatory cells, inflammatory markers were decreased, and reductions in M1 phenotype markers in activated macrophages were reported.
Reduction in inflammation is described as one of the most reproducible effects, with reported reductions in reactive nitrogen species and prostaglandins across various animal models.
What the results mean
There is a coherent, specific, physically plausible mechanism. That is more than can be said for many wellness technologies and it is a legitimate reason to take the category seriously.
The dose relationship is the practical consequence. Because the response is biphasic, the correct question about a panel is not 'how powerful is it' but 'what dose does it deliver at the distance I will stand, over the time I will stand there'. A panel that overshoots is not a better panel.
What is not supported by this review is any specific human clinical outcome. Cell and animal mechanisms establish possibility. They do not establish that a person standing in front of an LED array will experience a measurable benefit.
What this study does not prove
- It does not establish any clinical outcome in humans. The evidence is predominantly mechanistic and preclinical.
- It does not establish that consumer LED panels deliver doses in the effective range.
- It does not identify an optimal wavelength, irradiance, or dose for any application.
- Animal model findings on inflammation do not transfer directly to human tissue outcomes.
- It does not support claims that red light treats, cures, prevents, or mitigates any disease.
- The context-dependence described - effects differing between healthy and stressed cells - means results in disease models cannot be assumed to apply to healthy users.
Evidence strength
Mechanistic review
A mechanistic review explains how an intervention could work, drawing on cell and animal studies. It sits near the bottom of the hierarchy for establishing clinical effect and near the top for explaining plausibility.
That distinction matters here. Nothing in this review demonstrates that a consumer LED panel produces a clinical result. What it does is explain why light at particular wavelengths and doses might do anything at all - and why more is not better.
Strengths and limitations
Strengths
- Detailed and specific mechanistic account with identified chromophores rather than vague appeals to cellular energy.
- Explicitly describes the biphasic dose response, which is the most practically important concept in the field.
- Distinguishes effects in normal cells from effects in stressed or inflamed cells.
- Covers a wide range of tissues and models.
- Written by a leading researcher in the field and widely cited.
Limitations
- Predominantly preclinical; limited direct human clinical evidence.
- Not a systematic review; no protocol or bias assessment.
- Wavelength, irradiance and dose vary across the studies discussed and are not standardised.
- Many findings come from animal disease models with no healthy-human equivalent.
- Does not distinguish laser sources from LED sources in terms of clinical equivalence.
- No effect sizes are generated.
Does this apply to the equipment IMPERVITA sells?
This is mechanism research, much of it using laser or research-grade equipment rather than consumer LED panels. It should not be read as evidence that any particular panel produces a clinical effect.
What does apply, and applies strongly, is the buying logic that follows from the biphasic dose response. If effect depends on dose, and dose is irradiance multiplied by time, then a manufacturer who cannot state irradiance at a defined distance cannot tell you what dose their product delivers - and therefore cannot claim to be operating in the effective range.
That makes this review the most useful entry in the library for comparing panels, despite containing no clinical evidence at all.
Evidence in context
A 2021 critical review of the molecular evidence reached a more sceptical position, noting the lack of regulatory standards and examining the differences between laser light, on which much preclinical evidence is based, and the diodes typically used clinically and at home.
On the human side, a 2016 review of photobiomodulation in human muscle tissue identified 46 clinical studies with 1,045 participants, reporting increased muscle mass gains after training and decreased inflammation and oxidative stress in muscle biopsies - though with wide device heterogeneity.
A 2023 systematic review found no clinical trial evidence linking photobiomodulation with significant adverse events in skin rejuvenation. The mechanism described here has not been overturned; the clinical translation remains incomplete.
Related research
- Photobiomodulation: a review of the molecular evidence for low level light therapy A more sceptical critical review examining laser versus diode evidence and the absence of regulatory standards.
- Photobiomodulation in human muscle tissue: an advantage in sports performance? The human clinical counterpart, reviewing 46 trials in muscle tissue.
- Photobiomodulation: a systematic review of the oncologic safety of low-level light therapy for aesthetic skin rejuvenation Systematic review of oncologic safety, the most directly safety-relevant entry in this group.
- Low-level light/laser therapy versus photobiomodulation therapy The terminology consensus that established 'photobiomodulation' as the preferred term.
Practical buyer relevance
This entry translates into three concrete questions to ask about any panel.
First, what wavelengths does it emit, in nanometres? The chromophores absorb at specific wavelengths, so 'red and near-infrared' is not an answer.
Second, what is the irradiance at the distance I would actually use, in mW/cm²? Irradiance falls off sharply with distance, so a figure quoted at three inches tells you nothing about standing at eighteen.
Third, what dose does a session deliver in J/cm²? Because the response is biphasic, this is the number that matters, and it is the one a serious manufacturer can supply.
A seller leading with total wattage and LED count is describing what the device draws and how many diodes it contains - neither of which is what reaches you.
Safety context
Follow the eye-safety guidance supplied with the specific device. High-output red and near-infrared sources warrant eye protection, and manufacturer instructions should be treated as requirements rather than suggestions.
People with a photosensitising condition, taking photosensitising medication, with a history of skin cancer, or who are pregnant may require guidance from a qualified healthcare professional before use. A device with no stated contraindication list is less carefully documented, not safer.
Full source record
- Title
- Mechanisms and Applications of the Anti-Inflammatory Effects of Photobiomodulation
- Authors
- Hamblin MR
- Organization
- Wellman Center for Photomedicine, Massachusetts General Hospital / Harvard Medical School
- Publication
- AIMS Biophysics
- Year
- 2017
- Volume / issue / pages
- Volume 4, issue 3, pages 337-361
- PMID
- 28748217
- PMCID
- PMC5523874
- Study type
- Mechanistic review
- Sample size
- Not applicable - mechanistic review
- Population
- Cell cultures, animal models of disease, and some human contexts
- Topic
- Recovery, Red Light
- Document type
- Narrative review
- Technology context
- Photobiomodulation mechanism research - largely preclinical, including laser and LED sources
- Related equipment context
- Red Light Therapy
- Source last verified
- 19 August 2026
References
- Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
- Photobiomodulation: a review of the molecular evidence for low level light therapy
- Photobiomodulation in human muscle tissue: an advantage in sports performance?
- Photobiomodulation: a systematic review of the oncologic safety of low-level light therapy for aesthetic skin rejuvenation
- Low-level light/laser therapy versus photobiomodulation therapy
Information provided by IMPERVITA is for educational and general wellness purposes and is not intended to replace professional medical advice, diagnosis, or treatment.
